Physician

Moises Alexander Chica, MD

According to 2025 Medicare claims, Moises Chica, MD (NPI: 1245212232) practices ophthalmology in the San Antonio-New Braunfels, TX market, with the plurality of this provider's patient population coming from Bexar, TX. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF HOUSTON PLLC (NPI: 1619135647; TIN: 74-2109903) and primary practice location at 78240-1670.

Chica's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,039 traditional Medicare patients, billed 33,076 HCPCS/CPT codes, and received $3,608,541 in Medicare payments. The top billing code was 67028 (Injection of drug into eye). Part D data shows 387 prescription claims across 120 beneficiaries totaling $34,673 in drug costs, led by Bromfenac Sodium (Bromfenac Sodium). Open Payments data shows 50 records totaling $57,915. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,858,745 to $3,608,541. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $22,743 and ending at $34,673. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.8M$3.6M2015 Medicare payment: $1,858,745 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $2,020,688 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $2,493,616 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,232,800 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,612,376 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,598,623 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $2,679,556 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $2,783,056 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,889,315 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $3,608,541 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201583911,877$1,858,745
201695212,402$2,020,688
20171,02714,425$2,493,616
201895614,106$2,232,800
20191,02415,914$2,612,376
202086515,160$2,598,623
202190615,895$2,679,556
202292515,568$2,783,056
202391031,497$2,889,315
20241,03933,076$3,608,541

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$22K$43K2015 Drug cost: $22,743 (USD; Tot_Drug_Cst)2016 Drug cost: $31,744 (USD; Tot_Drug_Cst)2017 Drug cost: $33,873 (USD; Tot_Drug_Cst)2018 Drug cost: $41,728 (USD; Tot_Drug_Cst)2019 Drug cost: $41,275 (USD; Tot_Drug_Cst)2020 Drug cost: $43,294 (USD; Tot_Drug_Cst)2021 Drug cost: $32,538 (USD; Tot_Drug_Cst)2022 Drug cost: $36,414 (USD; Tot_Drug_Cst)2023 Drug cost: $22,844 (USD; Tot_Drug_Cst)2024 Drug cost: $34,673 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201577197$22,743
201691262$31,744
201790265$33,873
201887265$41,728
201972220$41,275
202088255$43,294
202174200$32,538
202282229$36,414
202390222$22,844
2024120387$34,673

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
67028Injection of drug into eye4241,452$99
92014Established patient complete exam of visual system7421,004$90
92012Established patient problem focused exam of visual system311514$66
92134Imaging of retina8151,821$30
92250Photography of the retina315372$28

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Bromfenac SodiumBromfenac Sodium1122,605$13,512
IlevroNepafenac11270$3,965
Prednisolone AcetatePrednisolone Acetate602,781$2,177
Dorzolamide-TimololDorzolamide/Timolol/Pf16480$1,241
Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat382,845$751

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.31$5,209Alimera Sciences, Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.19$52,707Alimera Sciences, Inc.
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Moises Alexander Chica, MD?

Tedicare shows public-source Medicare data for Moises Alexander Chica, MD (NPI 1245212232), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Moises Alexander Chica, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Moises Alexander Chica, MD?

Moises Alexander Chica, MD is linked to RETINA CONSULTANTS OF HOUSTON PLLC (billing NPI 1619135647) in the available physician profile data.

Does Moises Alexander Chica, MD have Open Payments data?

Moises Alexander Chica, MD has 50 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.